EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug-Coated Balloon vs. Drug-Eluting Stents for De Novo Unprotected Left Main Stem Disease: The SPARTAN-LMS Study

Tharusha D Gunawardena, Natasha Corballis, Ioannis Merinopoulos, Upul Wickramarachchi, Johannes Reinhold, Clint Maart, Sulfi Sreekumar, Chris Sawh, Trevor Wistow, Toomas Sarev iD, Alisdair Ryding, Tim J Gilbert und 3 weitere

Journal of Cardiovascular Development and Disease · 16.02.2023 · 10 (2) · 84

DOI: 10.3390/jcdd10020084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 16.02.2023. Verfasst von Tharusha D Gunawardena und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this study is to compare the outcomes of patients treated with drug-coated balloons (DCBs) or second-generation drug-eluting stents (DESs) for de novo unprotected left main stem (LMS) disease. Previous studies comparing the treatment of LMS disease suggest that the mortality for DES PCI is not worse than CABG. There are limited data from studies investigating the treatment of de novo LMS disease with DCB angioplasty. We compared the all-cause and cardiac mortality of patients treated with paclitaxel DCB to those with second-generation DES for de novo LMS disease from July 2014 to November 2019. Data were analysed using Kaplan–Meier analyses and propensity-matched analyses. A total of 148 patients were treated with either a DCB or DES strategy. There was no significant difference in all-cause mortality in the DCB group (19.5%) compared to the DES group (15.9%) (HR 1.42 [0.61–3.32], p = 0.42). Regarding cardiac mortality, 2 (4.9%) were recorded for the DCB group and 7 (6.5%) for the DES group (HR 1.21 [0.31–4.67], p = 0.786); for target vessel myocardial infarction, there were 0 (0%) for the DCB group and 7 (6.5%) for the DES group; and for target lesion revascularisation, there were 3 (7.3%) in the DCB group and 9 (8.3%) in the DES group (HR: 0.89 [0.24–3.30]). p = 0.86. These remained not significant after propensity score matching. We found no difference in the mortality outcomes with DCB angioplasty compared to second-generation DES, with a median follow-up of 33 months. DCB can therefore be regarded as a safe option in the treatment of LMS disease in suitable patients.

Schlagwörter

Stichwörter der Autor:innen

complex coronary interventiondrug-coated balloondrug-eluting stentleft main stem

Autor:innen und Institutionen

  • Department of Cardiology, Norfolk and Norwich University Hospital, Norwich NR4 7UY, UK.
  • Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK.
  • Royal Brompton Hospital, London SW3 6NP, UK.

ORCID-Profile: Toomas Sarev, Vassilios S Vassiliou

Zitieren

APA

Gunawardena, T. D., Corballis, N., Merinopoulos, I., Wickramarachchi, U., Reinhold, J., Maart, C., Sreekumar, S., Sawh, C., Wistow, T., Sarev, T., Ryding, A., Gilbert, T. J., Clark, A., Vassiliou, V. S., & Eccleshall, S. (2023). Drug-Coated Balloon vs. Drug-Eluting Stents for De Novo Unprotected Left Main Stem Disease: The SPARTAN-LMS Study. Journal of Cardiovascular Development and Disease, 10(2), 84. https://doi.org/10.3390/jcdd10020084

Vancouver

Gunawardena TD, Corballis N, Merinopoulos I, Wickramarachchi U, Reinhold J, Maart C, et al. Drug-Coated Balloon vs. Drug-Eluting Stents for De Novo Unprotected Left Main Stem Disease: The SPARTAN-LMS Study. Journal of Cardiovascular Development and Disease. 2023;10(2):84. doi:10.3390/jcdd10020084

BibTeX
@article{Gunawardena2023,
  author = {Gunawardena, Tharusha D and Corballis, Natasha and Merinopoulos, Ioannis and Wickramarachchi, Upul and Reinhold, Johannes and Maart, Clint and Sreekumar, Sulfi and Sawh, Chris and Wistow, Trevor and Sarev, Toomas and Ryding, Alisdair and Gilbert, Tim J and Clark, Allan and Vassiliou, Vassilios S and Eccleshall, Simon},
  title = {Drug-Coated Balloon vs. Drug-Eluting Stents for De Novo Unprotected Left Main Stem Disease: The SPARTAN-LMS Study},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2023},
  volume = {10},
  number = {2},
  pages = {84},
  doi = {10.3390/jcdd10020084}
}
Kostenlos starten →